Biotechnology
The Biotechnology industry has a total of 675 stocks, with a combined market cap of $754.45 billion and total revenue of $92.45 billion.
Market Cap
754.45B
Revenue
92.45B
Profits
-48.47B
PE Ratio
n/a
Profit Margin
-52.42%
Dividend Yield
0.05%
660 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 124.77B | -2.92% | 1,391,451 | 11.02B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 58.79B | -1.55% | 875,713 | 14.20B |
| 3 | ARGX | argenx SE | 36.27B | -2.94% | 227,097 | 2.25B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.84B | 0.25% | 1,010,279 | 2.25B |
| 5 | ONC | BeiGene, Ltd. | 24.58B | -4.48% | 575,677 | 3.81B |
| 6 | BNTX | BioNTech SE | 23.58B | -0.74% | 625,556 | 2.85B |
| 7 | RPRX | Royalty Pharma plc | 18.56B | -0.80% | 3,057,393 | 2.26B |
| 8 | SMMT | Summit Therapeutics Inc. | 17.00B | -6.38% | 3,642,567 | - |
| 9 | INSM | Insmed Incorporated | 12.71B | -1.14% | 1,529,463 | 363.71M |
| 10 | GMAB | Genmab A/S | 12.46B | 0.21% | 940,320 | 2.99B |
| 11 | BMRN | BioMarin Pharmaceutical Inc. | 11.28B | -2.00% | 1,244,458 | 2.85B |
| 12 | INCY | Incyte Corporation | 11.18B | -1.21% | 1,464,871 | 4.24B |
| 13 | EXEL | Exelixis, Inc. | 10.12B | -1.07% | 2,694,837 | 2.17B |
| 14 | MRNA | Moderna, Inc. | 9.74B | -4.00% | 5,476,420 | 3.24B |
| 15 | ASND | Ascendis Pharma A/S | 9.46B | 2.75% | 410,058 | 376.48M |
| 16 | TECH | Bio-Techne Corporation | 7.90B | -2.14% | 1,609,294 | 1.20B |
| 17 | HALO | Halozyme Therapeutics, Inc. | 7.27B | -4.01% | 1,707,112 | 1.02B |
| 18 | ROIV | Roivant Sciences Ltd. | 7.15B | -0.40% | 4,706,805 | 122.59M |
| 19 | CORT | Corcept Therapeutics Incorporated | 6.82B | -7.17% | 1,510,013 | 675.04M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.80B | -4.15% | 603,753 | 180.13M |
| 21 | RVMD | Revolution Medicines, Inc. | 6.73B | -0.37% | 1,458,936 | - |
| 22 | BBIO | BridgeBio Pharma, Inc. | 6.44B | -1.24% | 2,438,672 | 221.90M |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 6.17B | -1.21% | 805,180 | 4.07B |
| 24 | LEGN | Legend Biotech Corporation | 6.14B | -0.80% | 2,608,685 | 627.24M |
| 25 | TLX | Telix Pharmaceuticals Limited | 5.58B | -1.49% | 32,727 | 484.69M |
| 26 | TGTX | TG Therapeutics, Inc. | 5.55B | -2.10% | 3,031,939 | 329.00M |
| 27 | BPMC | Blueprint Medicines Corporation | 5.25B | 0.81% | 783,877 | 508.82M |
| 28 | SRPT | Sarepta Therapeutics, Inc. | 5.23B | -0.88% | 1,443,733 | 1.90B |
| 29 | AXSM | Axsome Therapeutics, Inc. | 5.09B | 0.62% | 460,415 | 385.69M |
| 30 | ADMA | ADMA Biologics, Inc. | 5.04B | -4.15% | 4,653,191 | 426.45M |
| 31 | NUVL | Nuvalent, Inc. | 5.01B | -1.09% | 1,058,386 | - |
| 32 | VRNA | Verona Pharma plc | 4.95B | -0.29% | 600,626 | 42.28M |
| 33 | KRYS | Krystal Biotech, Inc. | 4.74B | -2.62% | 343,020 | 290.52M |
| 34 | CYTK | Cytokinetics, Incorporated | 4.64B | 1.35% | 3,004,565 | 18.47M |
| 35 | IONS | Ionis Pharmaceuticals, Inc. | 4.51B | -0.25% | 1,627,006 | 705.14M |
| 36 | RYTM | Rhythm Pharmaceuticals, Inc. | 3.87B | -1.53% | 348,829 | 130.13M |
| 37 | PCVX | Vaxcyte, Inc. | 3.75B | -3.67% | 2,073,864 | - |
| 38 | PTCT | PTC Therapeutics, Inc. | 3.66B | -1.13% | 708,688 | 806.78M |
| 39 | ACLX | Arcellx, Inc. | 3.33B | -1.24% | 920,813 | 107.94M |
| 40 | RARE | Ultragenyx Pharmaceutical Inc. | 3.28B | -1.05% | 746,166 | 560.23M |
| 41 | CRSP | CRISPR Therapeutics AG | 3.24B | -3.00% | 1,647,348 | 37.31M |
| 42 | SLNO | Soleno Therapeutics, Inc. | 3.21B | -0.46% | 1,030,633 | - |
| 43 | ZLAB | Zai Lab Limited | 3.17B | -4.76% | 1,291,926 | 398.99M |
| 44 | RNA | Avidity Biosciences, Inc. | 3.10B | -3.52% | 1,561,197 | 10.90M |
| 45 | AKRO | Akero Therapeutics, Inc. | 2.98B | -1.68% | 498,122 | - |
| 46 | MRUS | Merus N.V. | 2.90B | -3.03% | 1,058,132 | 36.13M |
| 47 | SWTX | SpringWorks Therapeutics, Inc. | 2.83B | 0.51% | 1,676,426 | 191.59M |
| 48 | SRRK | Scholar Rock Holding Corporation | 2.82B | -1.52% | 1,577,301 | - |
| 49 | PTGX | Protagonist Therapeutics, Inc. | 2.81B | -2.45% | 1,329,790 | 434.43M |
| 50 | CRNX | Crinetics Pharmaceuticals, Inc. | 2.75B | -0.47% | 706,748 | 1.04M |
| 51 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.69B | -4.22% | 1,093,291 | 491.73M |
| 52 | VKTX | Viking Therapeutics, Inc. | 2.65B | 2.12% | 3,366,912 | - |
| 53 | XENE | Xenon Pharmaceuticals Inc. | 2.57B | 1.79% | 694,967 | - |
| 54 | IMVT | Immunovant, Inc. | 2.52B | -4.07% | 1,978,651 | - |
| 55 | ACAD | ACADIA Pharmaceuticals Inc. | 2.43B | -2.80% | 1,147,140 | 957.80M |
| 56 | MLTX | MoonLake Immunotherapeutics | 2.34B | 0.49% | 290,543 | - |
| 57 | APLS | Apellis Pharmaceuticals, Inc. | 2.28B | -4.16% | 1,699,940 | 781.37M |
| 58 | RXRX | Recursion Pharmaceuticals, Inc. | 2.14B | -5.67% | 15,694,245 | 58.84M |
| 59 | IBRX | ImmunityBio, Inc. | 2.12B | -10.79% | 8,278,056 | 14.75M |
| 60 | FOLD | Amicus Therapeutics, Inc. | 2.06B | -2.90% | 3,313,665 | 528.30M |
| 61 | TARS | Tarsus Pharmaceuticals, Inc. | 2.05B | 0.55% | 403,604 | 182.95M |
| 62 | VCEL | Vericel Corporation | 2.05B | -3.12% | 418,263 | 237.22M |
| 63 | LGND | Ligand Pharmaceuticals Incorporated | 2.01B | -2.04% | 77,967 | 167.13M |
| 64 | BHVN | Biohaven Ltd. | 1.91B | 0.65% | 1,430,615 | - |
| 65 | MIRM | Mirum Pharmaceuticals, Inc. | 1.90B | 0.16% | 315,225 | 336.89M |
| 66 | APGE | Apogee Therapeutics, Inc. | 1.86B | -2.66% | 678,426 | - |
| 67 | MTSR | Metsera, Inc. | 1.84B | 2.27% | 1,068,281 | - |
| 68 | BLTE | Belite Bio, Inc | 1.82B | -2.72% | 11,316 | - |
| 69 | DNLI | Denali Therapeutics Inc. | 1.82B | -4.48% | 1,435,100 | - |
| 70 | NAMS | NewAmsterdam Pharma Company N.V. | 1.76B | -0.37% | 292,553 | 45.56M |
| 71 | JANX | Janux Therapeutics, Inc. | 1.70B | -1.27% | 420,023 | 10.59M |
| 72 | KYMR | Kymera Therapeutics, Inc. | 1.62B | -1.73% | 718,293 | 47.07M |
| 73 | AAPG | Ascentage Pharma Group International | 1.62B | -2.98% | - | 134.35M |
| 74 | GLPG | Galapagos NV | 1.62B | 2.78% | 265,214 | 285.38M |
| 75 | BEAM | Beam Therapeutics Inc. | 1.62B | -3.82% | 1,738,779 | 63.52M |
| 76 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | -2.82% | 754,026 | 714.73M |
| 77 | CNTA | Centessa Pharmaceuticals plc | 1.58B | -0.92% | 787,733 | - |
| 78 | AGIO | Agios Pharmaceuticals, Inc. | 1.56B | -2.44% | 548,633 | 36.50M |
| 79 | CGON | CG Oncology, Inc. | 1.54B | 0.60% | 1,237,783 | 1.14M |
| 80 | ARQT | Arcutis Biotherapeutics, Inc. | 1.54B | -1.74% | 1,826,079 | 196.54M |
| 81 | SPRY | ARS Pharmaceuticals, Inc. | 1.46B | -0.73% | 1,809,148 | 89.15M |
| 82 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.43B | -11.81% | 3,772,726 | 2.50M |
| 83 | IRON | Disc Medicine, Inc. | 1.42B | -0.75% | 546,663 | - |
| 84 | IDYA | IDEAYA Biosciences, Inc. | 1.42B | -4.65% | 1,217,959 | 7.00M |
| 85 | IMCR | Immunocore Holdings plc | 1.40B | 1.79% | 735,485 | 310.20M |
| 86 | MNKD | MannKind Corporation | 1.38B | -2.69% | 2,319,686 | 285.50M |
| 87 | VERA | Vera Therapeutics, Inc. | 1.35B | -1.71% | 527,950 | - |
| 88 | MESO | Mesoblast Limited | 1.31B | -3.95% | 77,418 | 5.67M |
| 89 | TVTX | Travere Therapeutics, Inc. | 1.29B | -2.28% | 1,155,785 | 233.18M |
| 90 | BTX | BlackRock Innovation and Growth Term Trust | 1.28B | -2.17% | 592,881 | - |
| 91 | EWTX | Edgewise Therapeutics, Inc. | 1.24B | 0.54% | 1,603,431 | - |
| 92 | CLDX | Celldex Therapeutics, Inc. | 1.18B | -3.10% | 1,017,680 | 7.02M |
| 93 | LQDA | Liquidia Corporation | 1.17B | 0.59% | 704,109 | 14.00M |
| 94 | OCUL | Ocular Therapeutix, Inc. | 1.14B | -4.78% | 2,068,616 | 63.72M |
| 95 | INVA | Innoviva, Inc. | 1.13B | -0.06% | 688,891 | 358.71M |
| 96 | ADPT | Adaptive Biotechnologies Corporation | 1.11B | -3.23% | 860,044 | 178.96M |
| 97 | ARDX | Ardelyx, Inc. | 1.10B | -0.86% | 3,501,862 | 333.62M |
| 98 | GPCR | Structure Therapeutics Inc. | 1.06B | -1.96% | 663,322 | - |
| 99 | AUPH | Aurinia Pharmaceuticals Inc. | 1.05B | -1.03% | 966,738 | 235.13M |
| 100 | VRDN | Viridian Therapeutics, Inc. | 1.03B | -1.17% | 1,873,232 | 302.00K |
| 101 | IOVA | Iovance Biotherapeutics, Inc. | 1.01B | -4.95% | 8,144,870 | 164.07M |
| 102 | NVAX | Novavax, Inc. | 997.23M | -2.97% | 3,814,796 | 682.16M |
| 103 | MDXG | MiMedx Group, Inc. | 977.04M | -3.01% | 489,657 | 348.88M |
| 104 | OCS | Oculis Holding AG | 954.05M | 0.50% | 28,923 | 757.02K |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 950.57M | -2.56% | 1,571,952 | 23.68M |
| 106 | WVE | Wave Life Sciences Ltd. | 896.36M | -7.01% | 993,878 | 108.30M |
| 107 | DYN | Dyne Therapeutics, Inc. | 885.74M | -0.25% | 1,455,086 | - |
| 108 | MLYS | Mineralys Therapeutics, Inc. | 874.03M | -2.59% | 478,097 | - |
| 109 | ETNB | 89bio, Inc. | 859.85M | -2.64% | 1,351,026 | - |
| 110 | RCUS | Arcus Biosciences, Inc. | 830.82M | -2.00% | 882,982 | 258.00M |
| 111 | CMRX | Chimerix, Inc. | 802.02M | -0.06% | 1,963,135 | 212.00K |
| 112 | GERN | Geron Corporation | 789.76M | -0.80% | 12,350,059 | 76.99M |
| 113 | ELVN | Enliven Therapeutics, Inc. | 787.50M | -5.75% | 232,824 | - |
| 114 | ZYME | Zymeworks Inc. | 782.74M | 2.83% | 638,370 | 76.30M |
| 115 | AVXL | Anavex Life Sciences Corp. | 751.97M | -3.84% | 602,074 | - |
| 116 | SYRE | Spyre Therapeutics, Inc. | 748.62M | -2.28% | 573,432 | - |
| 117 | PHVS | Pharvaris N.V. | 747.65M | -1.58% | 23,397 | - |
| 118 | NRIX | Nurix Therapeutics, Inc. | 747.11M | -0.20% | 1,056,487 | 56.42M |
| 119 | VIR | Vir Biotechnology, Inc. | 745.37M | -3.29% | 766,335 | 74.21M |
| 120 | GYRE | Gyre Therapeutics, Inc. | 743.28M | -5.48% | 79,380 | 105.76M |
| 121 | CVAC | CureVac N.V. | 720.50M | -0.93% | 508,161 | 554.07M |
| 122 | ABCL | AbCellera Biologics Inc. | 712.19M | -1.65% | 4,423,176 | 28.83M |
| 123 | NTLA | Intellia Therapeutics, Inc. | 710.13M | -6.79% | 2,700,435 | 57.88M |
| 124 | DAWN | Day One Biopharmaceuticals, Inc. | 685.16M | -5.98% | 1,044,716 | 131.16M |
| 125 | XNCR | Xencor, Inc. | 670.09M | -0.31% | 1,205,874 | 110.49M |
| 126 | RCKT | Rocket Pharmaceuticals, Inc. | 655.77M | -5.82% | 3,166,409 | - |
| 127 | BCAX | Bicara Therapeutics Inc. | 641.19M | 2.71% | 649,599 | - |
| 128 | NUVB | Nuvation Bio Inc. | 636.72M | -7.43% | 3,429,703 | 7.87M |
| 129 | LENZ | LENZ Therapeutics, Inc. | 636.52M | -3.26% | 323,286 | - |
| 130 | XERS | Xeris Biopharma Holdings, Inc. | 628.08M | -6.85% | 1,969,032 | 203.07M |
| 131 | IMNM | Immunome, Inc. | 623.44M | -3.18% | 1,204,185 | 9.04M |
| 132 | SVRA | Savara Inc. | 616.69M | 0.17% | 443,229 | - |
| 133 | DNTH | Dianthus Therapeutics, Inc. | 609.74M | -1.87% | 228,998 | 6.24M |
| 134 | AVBP | ArriVent BioPharma, Inc. | 608.89M | -4.03% | 120,947 | - |
| 135 | PRAX | Praxis Precision Medicines, Inc. | 601.37M | 0.52% | 357,732 | 8.55M |
| 136 | TRVI | Trevi Therapeutics, Inc. | 589.76M | -1.61% | 765,771 | - |
| 137 | REPL | Replimune Group, Inc. | 587.62M | -1.04% | 674,225 | - |
| 138 | ABUS | Arbutus Biopharma Corporation | 585.93M | -3.16% | 1,123,210 | 6.17M |
| 139 | ANAB | AnaptysBio, Inc. | 584.51M | 5.30% | 955,485 | 91.28M |
| 140 | KALV | KalVista Pharmaceuticals, Inc. | 583.91M | -2.41% | 492,177 | - |
| 141 | VALN | Valneva SE | 553.87M | -6.88% | 11,036 | 175.56M |
| 142 | PHAR | Pharming Group N.V. | 549.35M | -0.86% | 2,416 | 297.20M |
| 143 | KROS | Keros Therapeutics, Inc. | 548.80M | 3.36% | 1,255,112 | 3.55M |
| 144 | GHRS | GH Research PLC | 539.64M | -2.67% | 132,565 | - |
| 145 | ARVN | Arvinas, Inc. | 526.10M | 0.92% | 2,901,646 | 263.40M |
| 146 | BCYC | Bicycle Therapeutics plc | 518.33M | -3.98% | 305,566 | 35.28M |
| 147 | NAGE | Niagen Bioscience, Inc. | 509.58M | 1.72% | 439,689 | 99.60M |
| 148 | QURE | uniQure N.V. | 507.78M | -2.69% | 851,315 | 27.12M |
| 149 | IMTX | Immatics N.V. | 499.57M | -5.95% | 362,820 | 161.34M |
| 150 | PRTA | Prothena Corporation plc | 498.44M | -3.55% | 400,084 | 135.16M |
| 151 | CRMD | CorMedix Inc. | 490.17M | 1.62% | 1,140,178 | 43.47M |
| 152 | URGN | UroGen Pharma Ltd. | 478.92M | -3.67% | 274,190 | 90.40M |
| 153 | COGT | Cogent Biosciences, Inc. | 472.00M | -11.91% | 2,330,566 | - |
| 154 | OPT | Opthea Limited | 466.57M | 1.49% | 3,025 | 208.86K |
| 155 | KURA | Kura Oncology, Inc. | 464.34M | -4.64% | 1,800,239 | 53.88M |
| 156 | TYRA | Tyra Biosciences, Inc. | 456.04M | -0.81% | 233,267 | - |
| 157 | SAGE | Sage Therapeutics, Inc. | 453.11M | -2.06% | 608,403 | 41.24M |
| 158 | FTRE | Fortrea Holdings Inc. | 452.80M | 3.29% | 2,901,671 | 2.70B |
| 159 | UPB | Upstream Bio, Inc. | 451.66M | 8.37% | 289,337 | 2.37M |
| 160 | CGEM | Cullinan Therapeutics, Inc. | 445.28M | -2.44% | 413,840 | - |
| 161 | RLAY | Relay Therapeutics, Inc. | 442.45M | -5.43% | 2,105,850 | 10.01M |
| 162 | SION | Sionna Therapeutics, Inc. | 441.24M | 5.04% | 137,952 | - |
| 163 | CAPR | Capricor Therapeutics, Inc. | 440.32M | -1.83% | 808,214 | 22.27M |
| 164 | DNA | Ginkgo Bioworks Holdings, Inc. | 439.82M | -1.94% | 932,523 | 227.04M |
| 165 | MRVI | Maravai LifeSciences Holdings, Inc. | 437.46M | -0.58% | 1,199,156 | 259.19M |
| 166 | TBPH | Theravance Biopharma, Inc. | 425.20M | -0.64% | 194,569 | 64.38M |
| 167 | MGTX | MeiraGTx Holdings plc | 419.11M | -2.48% | 260,798 | 33.28M |
| 168 | MNMD | Mind Medicine (MindMed) Inc. | 411.51M | -2.50% | 507,586 | - |
| 169 | STOK | Stoke Therapeutics, Inc. | 408.83M | -3.10% | 771,500 | 36.56M |
| 170 | PGEN | Precigen, Inc. | 402.84M | -4.86% | 889,433 | 3.93M |
| 171 | VERV | Verve Therapeutics, Inc. | 400.47M | -9.26% | 7,066,390 | 32.33M |
| 172 | OMER | Omeros Corporation | 392.51M | -1.60% | 392,036 | - |
| 173 | PRTC | PureTech Health plc | 388.99M | 0.42% | - | 468.00K |
| 174 | ABSI | Absci Corporation | 388.37M | -2.24% | 2,442,590 | 4.53M |
| 175 | ZVRA | Zevra Therapeutics, Inc. | 381.52M | 1.29% | 338,170 | 23.61M |
| 176 | EYPT | EyePoint Pharmaceuticals, Inc. | 379.38M | -2.65% | 458,771 | 43.27M |
| 177 | ABVX | ABIVAX Société Anonyme | 378.05M | 3.80% | 123,307 | 11.17M |
| 178 | CELC | Celcuity Inc. | 378.02M | -1.38% | 229,238 | - |
| 179 | TRML | Tourmaline Bio, Inc. | 372.95M | -2.75% | 257,375 | - |
| 180 | AUTL | Autolus Therapeutics plc | 359.27M | -3.57% | 1,109,531 | 10.12M |
| 181 | MAZE | Maze Therapeutics, Inc. | 358.25M | 0.99% | 103,159 | 167.50M |
| 182 | RAPP | Rapport Therapeutics, Inc. | 356.21M | 1.67% | 76,025 | - |
| 183 | SANA | Sana Biotechnology, Inc. | 355.54M | -7.06% | 1,820,600 | - |
| 184 | ZBIO | Zenas BioPharma, Inc. | 348.19M | -4.47% | 79,923 | 5.00M |
| 185 | BNTC | Benitec Biopharma Inc. | 347.87M | -1.90% | 49,400 | - |
| 186 | ALT | Altimmune, Inc. | 338.86M | -2.98% | 1,056,944 | 20.00K |
| 187 | MREO | Mereo BioPharma Group plc | 338.67M | 6.50% | 1,625,024 | 1.00M |
| 188 | AMLX | Amylyx Pharmaceuticals, Inc. | 338.46M | -1.55% | 495,459 | 87.37M |
| 189 | CKPT | Checkpoint Therapeutics, Inc. | 338.41M | 0.37% | 1,331,240 | 41.00K |
| 190 | ORIC | ORIC Pharmaceuticals, Inc. | 333.12M | -6.85% | 478,570 | - |
| 191 | ERAS | Erasca, Inc. | 331.42M | -0.84% | 793,199 | - |
| 192 | TECX | Tectonic Therapeutic, Inc. | 327.72M | -2.12% | 113,149 | - |
| 193 | ORKA | Oruka Therapeutics, Inc. | 322.36M | 0.58% | 186,582 | - |
| 194 | RGNX | REGENXBIO Inc. | 308.72M | -5.80% | 699,695 | 83.33M |
| 195 | IVA | Inventiva S.A. | 306.48M | -2.70% | 8,253 | 15.24M |
| 196 | ALLO | Allogene Therapeutics, Inc. | 304.17M | -4.11% | 1,273,398 | 22.00K |
| 197 | RIGL | Rigel Pharmaceuticals, Inc. | 294.63M | -3.23% | 186,410 | 179.28M |
| 198 | OLMA | Olema Pharmaceuticals, Inc. | 291.10M | 1.19% | 771,676 | - |
| 199 | PHAT | Phathom Pharmaceuticals, Inc. | 288.89M | -11.43% | 1,278,956 | 55.25M |
| 200 | NNNN | Anbio Biotechnology | 288.37M | 2.98% | 27,798 | 9.50M |
| 201 | ATAI | Atai Life Sciences N.V. | 281.60M | 2.52% | 896,791 | 308.00K |
| 202 | HRTX | Heron Therapeutics, Inc. | 280.29M | -4.17% | 859,988 | 144.29M |
| 203 | TRDA | Entrada Therapeutics, Inc. | 280.02M | -0.13% | 179,751 | 210.78M |
| 204 | ARCT | Arcturus Therapeutics Holdings Inc. | 279.33M | -2.55% | 399,875 | 152.31M |
| 205 | ALMS | Alumis Inc. | 275.85M | -0.78% | 258,453 | - |
| 206 | RNAC | Cartesian Therapeutics, Inc. | 273.84M | -11.95% | 121,708 | 38.91M |
| 207 | AURA | Aura Biosciences, Inc. | 271.22M | -3.23% | 138,061 | - |
| 208 | PVLA | Palvella Therapeutics, Inc. | 268.86M | 2.59% | 86,964 | - |
| 209 | GLUE | Monte Rosa Therapeutics, Inc. | 267.88M | -1.69% | 860,717 | 75.62M |
| 210 | ATYR | aTyr Pharma, Inc. | 267.46M | 0.67% | 887,125 | 235.00K |
| 211 | SEPN | Septerna, Inc. | 266.21M | -4.77% | 128,631 | 1.08M |
| 212 | TSVT | 2seventy bio, Inc. | 260.12M | - | 359,385 | 37.86M |
| 213 | AVIR | Atea Pharmaceuticals, Inc. | 256.58M | 6.38% | 446,542 | - |
| 214 | VSTM | Verastem, Inc. | 255.39M | 3.12% | 468,391 | 10.00M |
| 215 | VNDA | Vanda Pharmaceuticals Inc. | 254.84M | - | 376,212 | 198.77M |
| 216 | MBX | MBX Biosciences, Inc. | 251.02M | 1.76% | 313,148 | - |
| 217 | XOMA | XOMA Royalty Corporation | 245.92M | -1.30% | 9,540 | 28.49M |
| 218 | TSHA | Taysha Gene Therapies, Inc. | 241.90M | -7.09% | 812,496 | 8.33M |
| 219 | HUMA | Humacyte, Inc. | 240.43M | 0.65% | 1,724,464 | - |
| 220 | ITOS | iTeos Therapeutics, Inc. | 237.57M | 4.71% | 745,523 | 35.00M |
| 221 | ABEO | Abeona Therapeutics Inc. | 235.15M | -1.52% | 692,187 | - |
| 222 | CMPX | Compass Therapeutics, Inc. | 235.08M | -0.29% | 561,788 | 850.00K |
| 223 | PROK | ProKidney Corp. | 232.96M | 12.08% | 2,263,183 | 76.00K |
| 224 | MNPR | Monopar Therapeutics Inc. | 232.40M | -0.89% | 21,214 | - |
| 225 | THRD | Third Harmonic Bio, Inc. | 231.38M | 0.39% | 633,349 | - |
| 226 | DRUG | Bright Minds Biosciences Inc. | 225.56M | -1.23% | 16,412 | - |
| 227 | ATXS | Astria Therapeutics, Inc. | 224.61M | -3.29% | 263,476 | - |
| 228 | SLRN | Acelyrin, Inc. | 221.56M | -1.35% | 666,382 | - |
| 229 | CRVS | Corvus Pharmaceuticals, Inc. | 220.08M | -0.31% | 790,766 | - |
| 230 | OABI | OmniAb, Inc. | 216.18M | -5.56% | 562,306 | 26.39M |
| 231 | CADL | Candel Therapeutics, Inc. | 213.98M | -8.59% | 616,178 | - |
| 232 | CRGX | CARGO Therapeutics, Inc. | 213.68M | 1.98% | 565,681 | - |
| 233 | CDTX | Cidara Therapeutics, Inc. | 210.09M | -4.10% | 57,089 | 1.28M |
| 234 | IMMP | Immutep Limited | 209.16M | -3.97% | 114,935 | 3.02M |
| 235 | YMAB | Y-mAbs Therapeutics, Inc. | 205.29M | -15.51% | 261,506 | 87.69M |
| 236 | NVCT | Nuvectis Pharma, Inc. | 204.09M | -8.45% | 117,326 | - |
| 237 | PLX | Protalix BioTherapeutics, Inc. | 202.88M | -1.34% | 542,897 | 53.40M |
| 238 | ENGN | enGene Holdings Inc. | 201.87M | -1.00% | 82,832 | - |
| 239 | ENGNW | enGene Holdings Inc. | 201.87M | 1.49% | 2,137 | - |
| 240 | TERN | Terns Pharmaceuticals, Inc. | 195.55M | -6.88% | 980,734 | - |
| 241 | TENX | Tenax Therapeutics, Inc. | 195.40M | 0.37% | 8,374 | - |
| 242 | SLDB | Solid Biosciences Inc. | 195.28M | -6.67% | 970,918 | - |
| 243 | FHTX | Foghorn Therapeutics Inc. | 193.53M | -2.52% | 59,272 | 22.60M |
| 244 | DSGN | Design Therapeutics, Inc. | 191.86M | 0.90% | 105,105 | - |
| 245 | OCGN | Ocugen, Inc. | 190.74M | -6.53% | 4,031,881 | 4.06M |
| 246 | GOSS | Gossamer Bio, Inc. | 188.62M | 0.02% | 980,347 | 114.70M |
| 247 | TVGN | Tevogen Bio Holdings Inc. | 187.57M | -2.86% | 508,945 | - |
| 248 | CRDF | Cardiff Oncology, Inc. | 186.93M | -4.59% | 1,437,955 | 683.00K |
| 249 | HURA | TuHURA Biosciences, Inc. | 181.27M | 1.10% | 108,823 | - |
| 250 | LXRX | Lexicon Pharmaceuticals, Inc. | 180.75M | -2.36% | 4,955,921 | 31.08M |
| 251 | ELDN | Eledon Pharmaceuticals, Inc. | 179.65M | -0.50% | 152,156 | - |
| 252 | DRTS | Alpha Tau Medical Ltd. | 178.06M | -1.17% | 11,593 | - |
| 253 | GNFT | Genfit S.A. | 177.43M | -4.75% | 8,066 | 86.23M |
| 254 | MDWD | MediWound Ltd. | 176.06M | -1.28% | 9,451 | 20.22M |
| 255 | CDXS | Codexis, Inc. | 175.62M | -5.78% | 592,575 | 59.35M |
| 256 | VYGR | Voyager Therapeutics, Inc. | 172.80M | -2.49% | 241,423 | 80.00M |
| 257 | TVRD | Tvardi Therapeutics, Inc. | 170.73M | - | 51,828 | - |
| 258 | INMB | INmune Bio, Inc. | 167.62M | -2.14% | 230,818 | 14.00K |
| 259 | IPHA | Innate Pharma S.A. | 167.20M | 1.57% | 9,150 | 20.83M |
| 260 | INBX | Inhibrx Biosciences, Inc. | 166.04M | -2.71% | 63,201 | 200.00K |
| 261 | FULC | Fulcrum Therapeutics, Inc. | 165.18M | 0.66% | 202,913 | 80.00M |
| 262 | AARD | Aardvark Therapeutics, Inc. | 164.24M | -4.78% | 41,558 | - |
| 263 | NBTX | Nanobiotix S.A. | 161.84M | - | - | -7.44M |
| 264 | ACTU | Actuate Therapeutics, Inc. | 160.75M | 2.52% | 68,508 | - |
| 265 | RZLT | Rezolute, Inc. | 159.81M | 0.76% | 683,187 | - |
| 266 | PRME | Prime Medicine, Inc. | 159.58M | -5.30% | 806,156 | 2.98M |
| 267 | ANNX | Annexon, Inc. | 156.89M | -7.14% | 1,154,865 | - |
| 268 | CYBN | Cybin Inc. | 156.72M | -3.25% | 237,021 | - |
| 269 | SGMO | Sangamo Therapeutics, Inc. | 153.99M | -7.17% | 4,702,542 | 57.80M |
| 270 | NGNE | Neurogene Inc. | 153.60M | -5.24% | 112,118 | 925.00K |
| 271 | DBVT | DBV Technologies S.A. | 149.41M | 7.62% | 41,142 | 4.15M |
| 272 | DMAC | DiaMedica Therapeutics Inc. | 148.71M | -2.56% | 84,332 | - |
| 273 | ACIU | AC Immune SA | 148.41M | -0.66% | 80,937 | 30.14M |
| 274 | MOLN | Molecular Partners AG | 148.13M | -0.38% | 1,632 | 5.48M |
| 275 | IKT | Inhibikase Therapeutics, Inc. | 147.20M | 4.21% | 123,459 | 1.00 |
| 276 | TARA | Protara Therapeutics, Inc. | 147.07M | -4.56% | 420,014 | - |
| 277 | PBYI | Puma Biotechnology, Inc. | 142.88M | -3.04% | 163,031 | 230.47M |
| 278 | FENC | Fennec Pharmaceuticals Inc. | 140.73M | -2.86% | 33,451 | 47.54M |
| 279 | TNGX | Tango Therapeutics, Inc. | 138.38M | -5.09% | 380,184 | 42.07M |
| 280 | SLN | Silence Therapeutics plc | 136.95M | 3.57% | 280,786 | 43.26M |
| 281 | CGEN | Compugen Ltd. | 135.13M | 4.71% | 344,293 | 27.86M |
| 282 | FDMT | 4D Molecular Therapeutics, Inc. | 134.74M | -6.13% | 434,277 | 37.00K |
| 283 | NTHI | NeOnc Technologies Holdings, Inc. | 131.22M | -8.26% | 48,449 | 83.00K |
| 284 | LYEL | Lyell Immunopharma, Inc. | 129.61M | -4.32% | 682,861 | 61.00K |
| 285 | RGLS | Regulus Therapeutics Inc. | 128.51M | -0.51% | 462,057 | - |
| 286 | SCPH | scPharmaceuticals Inc. | 128.22M | -3.78% | 251,219 | 36.33M |
| 287 | KRRO | Korro Bio, Inc. | 126.37M | 0.45% | 117,777 | 2.27M |
| 288 | KLRS | Kalaris Therapeutics, Inc. | 125.31M | 3.72% | 109,300 | - |
| 289 | KOD | Kodiak Sciences Inc. | 124.20M | 2.16% | 248,512 | - |
| 290 | NKTX | Nkarta, Inc. | 124.18M | 2.34% | 1,325,490 | - |
| 291 | FATE | Fate Therapeutics, Inc. | 120.33M | -6.25% | 1,659,885 | 13.63M |
| 292 | ALDX | Aldeyra Therapeutics, Inc. | 120.01M | -8.64% | 1,367,420 | - |
| 293 | PRQR | ProQR Therapeutics N.V. | 119.94M | -3.78% | 331,571 | 20.24M |
| 294 | CUPR | Cuprina Holdings (Cayman) Limited | 118.92M | 16.31% | 260,220 | 71.62K |
| 295 | THTX | Theratechnologies Inc. | 118.58M | -3.38% | 2,302,634 | 88.67M |
| 296 | SEER | Seer, Inc. | 118.37M | -5.71% | 106,252 | 14.17M |
| 297 | LRMR | Larimar Therapeutics, Inc. | 117.81M | -2.13% | 518,942 | - |
| 298 | CHRS | Coherus BioSciences, Inc. | 117.06M | -4.72% | 1,745,632 | 266.96M |
| 299 | SLS | SELLAS Life Sciences Group, Inc. | 116.28M | -0.78% | 1,532,723 | - |
| 300 | GLSI | Greenwich LifeSciences, Inc. | 115.48M | -2.79% | 55,531 | - |
| 301 | ADCT | ADC Therapeutics SA | 114.94M | -4.13% | 155,654 | 70.84M |
| 302 | EPRX | Eupraxia Pharmaceuticals Inc. | 114.67M | -5.23% | 4,368 | - |
| 303 | CSBR | Champions Oncology, Inc. | 113.90M | 3.36% | 30,455 | 58.59M |
| 304 | CTNM | Contineum Therapeutics, Inc. | 113.32M | 6.57% | 174,692 | - |
| 305 | NKTR | Nektar Therapeutics | 112.35M | -5.33% | 2,263,945 | 98.43M |
| 306 | CLLS | Cellectis S.A. | 110.41M | -4.11% | 46,914 | 49.22M |
| 307 | OBIO | Orchestra BioMed Holdings, Inc. | 109.57M | 1.42% | 40,914 | 2.64M |
| 308 | RAPT | RAPT Therapeutics, Inc. | 105.75M | -6.57% | 601,555 | - |
| 309 | EDIT | Editas Medicine, Inc. | 105.38M | -5.93% | 1,286,212 | 32.31M |
| 310 | ENTA | Enanta Pharmaceuticals, Inc. | 105.17M | -4.56% | 358,170 | 66.59M |
| 311 | TNXP | Tonix Pharmaceuticals Holding Corp. | 102.06M | -6.71% | 576,555 | 10.09M |
| 312 | NMRA | Neumora Therapeutics, Inc. | 102.05M | -2.96% | 1,017,796 | - |
| 313 | SNTI | Senti Biosciences, Inc. | 99.86M | 4.63% | 19,097 | - |
| 314 | TIL | Instil Bio, Inc. | 99.85M | -7.16% | 51,729 | - |
| 315 | TLSA | Tiziana Life Sciences Ltd | 97.09M | 9.88% | 607,428 | - |
| 316 | ALEC | Alector, Inc. | 96.94M | -9.75% | 628,240 | 100.56M |
| 317 | GNLX | Genelux Corporation | 95.85M | - | 87,585 | 8.00K |
| 318 | LCTX | Lineage Cell Therapeutics, Inc. | 95.18M | 1.59% | 1,064,208 | 9.50M |
| 319 | EXOZ | eXoZymes, Inc. | 93.05M | -5.36% | 1,303 | -700.00 |
| 320 | NAUT | Nautilus Biotechnology, Inc. | 91.24M | -6.08% | 152,096 | - |
| 321 | ZNTL | Zentalis Pharmaceuticals, Inc. | 90.48M | -0.79% | 1,003,318 | 67.43M |
| 322 | IMUX | Immunic, Inc. | 90.31M | -4.61% | 386,216 | - |
| 323 | XBIT | XBiotech Inc. | 90.24M | -6.92% | 66,751 | - |
| 324 | ORMP | Oramed Pharmaceuticals Inc. | 89.87M | -1.35% | 22,994 | - |
| 325 | ANIX | Anixa Biosciences, Inc. | 88.54M | -3.51% | 14,760 | - |
| 326 | PLRX | Pliant Therapeutics, Inc. | 88.18M | -1.37% | 565,129 | - |
| 327 | COYA | Coya Therapeutics, Inc. | 87.30M | -5.26% | 55,702 | 3.55M |
| 328 | GALT | Galectin Therapeutics Inc. | 86.56M | 2.24% | 82,013 | - |
| 329 | CLYM | Climb Bio, Inc. | 85.02M | -9.93% | 99,305 | - |
| 330 | CRVO | CervoMed Inc. | 83.11M | -2.25% | 408,312 | 9.74M |
| 331 | SRZN | Surrozen, Inc. | 81.55M | -0.72% | 7,052 | 10.66M |
| 332 | HLVX | HilleVax, Inc. | 81.22M | 0.30% | 296,923 | - |
| 333 | VOR | Vor Biopharma Inc. | 81.15M | -7.14% | 119,823 | - |
| 334 | ENTX | Entera Bio Ltd. | 79.94M | -0.55% | 17,425 | 181.00K |
| 335 | VXRT | Vaxart, Inc. | 79.53M | -1.83% | 996,060 | 28.70M |
| 336 | KYTX | Kyverna Therapeutics, Inc. | 79.08M | -7.81% | 222,489 | - |
| 337 | ZURA | Zura Bio Limited | 78.63M | 0.88% | 396,078 | - |
| 338 | EPIX | ESSA Pharma Inc. | 78.57M | 8.59% | 907,458 | - |
| 339 | ATOS | Atossa Therapeutics, Inc. | 78.15M | -2.68% | 603,036 | - |
| 340 | CCCC | C4 Therapeutics, Inc. | 78.09M | -7.56% | 1,056,144 | 35.58M |
| 341 | AVTE | Aerovate Therapeutics, Inc. | 77.68M | -0.37% | 109,473 | - |
| 342 | ELTX | Elicio Therapeutics, Inc. | 77.46M | -2.41% | 8,745 | - |
| 343 | VERU | Veru Inc. | 77.07M | 0.19% | 809,875 | 16.89M |
| 344 | BDTX | Black Diamond Therapeutics, Inc. | 77.06M | -4.23% | 516,406 | - |
| 345 | CNTX | Context Therapeutics Inc. | 76.43M | 1.07% | 80,692 | - |
| 346 | LXEO | Lexeo Therapeutics, Inc. | 75.69M | -10.59% | 565,531 | - |
| 347 | ASMB | Assembly Biosciences, Inc. | 75.07M | 1.99% | 8,658 | 28.52M |
| 348 | VTYX | Ventyx Biosciences, Inc. | 75.04M | -4.95% | 1,150,572 | - |
| 349 | TNYA | Tenaya Therapeutics, Inc. | 74.62M | -8.67% | 1,497,900 | - |
| 350 | MGNX | MacroGenics, Inc. | 74.45M | -6.35% | 705,150 | 149.96M |
| 351 | ADAG | Adagene Inc. | 74.43M | -1.25% | 21,428 | 103.20K |
| 352 | TELO | Telomir Pharmaceuticals, Inc. | 73.96M | -5.15% | 94,843 | - |
| 353 | TCRX | TScan Therapeutics, Inc. | 73.57M | 0.38% | 569,431 | 2.82M |
| 354 | ACHV | Achieve Life Sciences, Inc. | 73.19M | -2.31% | 129,969 | - |
| 355 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 72.41M | -1.17% | 138,122 | - |
| 356 | XCUR | Exicure, Inc. | 72.09M | -2.48% | 170,855 | 500.00K |
| 357 | WHWK | Whitehawk Therapeutics, Inc. | 72.05M | -8.33% | 132,379 | 25.98M |
| 358 | UNCY | Unicycive Therapeutics, Inc. | 71.58M | 0.74% | 213,332 | - |
| 359 | IGMS | IGM Biosciences, Inc. | 71.13M | -6.30% | 121,333 | 2.68M |
| 360 | MNOV | MediciNova, Inc. | 71.12M | 3.57% | 5,569 | - |
| 361 | GNTA | Genenta Science S.p.A. | 70.94M | 1.32% | 4,973 | - |
| 362 | ANL | Adlai Nortye Ltd. | 70.48M | -8.61% | - | 5.00M |
| 363 | VIGL | Vigil Neuroscience, Inc. | 70.47M | -1.94% | 36,905 | - |
| 364 | IFRX | InflaRx N.V. | 69.97M | -5.91% | 90,306 | 171.64K |
| 365 | MCRB | Seres Therapeutics, Inc. | 69.73M | -13.44% | 4,470,786 | - |
| 366 | IMAB | I-Mab | 68.57M | -7.26% | 137,816 | 569.46K |
| 367 | CRBU | Caribou Biosciences, Inc. | 68.17M | -5.92% | 915,759 | 9.99M |
| 368 | ACOG | Alpha Cognition Inc. | 68.08M | -6.51% | 55,517 | - |
| 369 | SAVA | Cassava Sciences, Inc. | 67.63M | -2.10% | 728,064 | - |
| 370 | RANI | Rani Therapeutics Holdings, Inc. | 66.10M | -5.79% | 48,395 | 1.03M |
| 371 | CLSD | Clearside Biomedical, Inc. | 65.83M | 3.83% | 84,958 | 1.66M |
| 372 | SGMT | Sagimet Biosciences Inc. | 65.03M | -6.45% | 365,423 | - |
| 373 | INO | Inovio Pharmaceuticals, Inc. | 63.07M | -2.27% | 420,414 | 217.76K |
| 374 | ADVM | Adverum Biotechnologies, Inc. | 62.67M | -7.12% | 328,983 | 1.00M |
| 375 | VANI | Vivani Medical, Inc. | 62.21M | 1.94% | 65,058 | - |
| 376 | INZY | Inozyme Pharma, Inc. | 61.90M | -3.37% | 484,260 | - |
| 377 | ADAP | Adaptimmune Therapeutics plc | 61.74M | -3.81% | 2,935,665 | 178.03M |
| 378 | ANRO | Alto Neuroscience, Inc. | 60.37M | -5.51% | 246,928 | - |
| 379 | VTVT | vTv Therapeutics Inc. | 60.03M | 1.29% | 6,845 | 1.02M |
| 380 | VTGN | Vistagen Therapeutics, Inc. | 59.74M | -10.81% | 178,354 | 698.00K |
| 381 | BMEA | Biomea Fusion, Inc. | 59.74M | -8.09% | 585,146 | - |
| 382 | ABOS | Acumen Pharmaceuticals, Inc. | 59.36M | -6.67% | 188,676 | - |
| 383 | JSPR | Jasper Therapeutics, Inc. | 58.89M | -7.33% | 119,488 | - |
| 384 | IOBT | IO Biotech, Inc. | 58.63M | 0.24% | 70,208 | - |
| 385 | ACRV | Acrivon Therapeutics, Inc. | 58.00M | -13.95% | 646,370 | - |
| 386 | RENB | Renovaro Inc. | 57.63M | -3.64% | 551,998 | - |
| 387 | PYXS | Pyxis Oncology, Inc. | 57.52M | 2.42% | 354,772 | 16.15M |
| 388 | IVVD | Invivyd, Inc. | 56.54M | -8.31% | 1,196,531 | 25.38M |
| 389 | ARTV | Artiva Biotherapeutics, Inc. | 56.04M | -2.13% | 186,927 | 251.00K |
| 390 | MGX | Metagenomi, Inc. | 55.33M | -5.73% | 459,937 | 52.30M |
| 391 | DOMH | Dominari Holdings Inc. | 55.19M | -2.53% | 113,270 | 18.15M |
| 392 | CBUS | Cibus, Inc. | 55.13M | -4.46% | 135,402 | 4.26M |
| 393 | CABA | Cabaletta Bio, Inc. | 54.80M | -3.57% | 649,578 | - |
| 394 | NTRB | Nutriband Inc. | 54.42M | -0.20% | 7,916 | 2.02M |
| 395 | GUTS | Fractyl Health, Inc. | 54.30M | -2.61% | 164,511 | 93.00K |
| 396 | MIST | Milestone Pharmaceuticals Inc. | 54.14M | -2.09% | 758,826 | - |
| 397 | KRON | Kronos Bio, Inc. | 53.65M | 1.38% | 74,357 | 9.85M |
| 398 | IKNA | Ikena Oncology, Inc. | 53.57M | -2.63% | 51,787 | - |
| 399 | DTIL | Precision BioSciences, Inc. | 52.51M | -8.33% | 156,145 | 68.70M |
| 400 | SER | Serina Therapeutics, Inc. | 52.14M | 3.14% | - | 56.00K |
| 401 | PMVP | PMV Pharmaceuticals, Inc. | 51.43M | -4.78% | 46,383 | - |
| 402 | BYSI | BeyondSpring Inc. | 50.80M | 4.13% | 16,846 | 1.88M |
| 403 | CTMX | CytomX Therapeutics, Inc. | 50.44M | -0.29% | 581,745 | 138.10M |
| 404 | AVTX | Avalo Therapeutics, Inc. | 49.41M | -5.51% | 26,466 | 441.00K |
| 405 | ICCC | ImmuCell Corporation | 49.31M | -0.19% | - | 26.49M |
| 406 | RPTX | Repare Therapeutics Inc. | 49.10M | 5.00% | 397,182 | 53.48M |
| 407 | SKYE | Skye Bioscience, Inc. | 48.94M | -7.60% | 1,166,500 | - |
| 408 | ONCY | Oncolytics Biotech Inc. | 48.66M | 0.66% | 147,306 | - |
| 409 | GANX | Gain Therapeutics, Inc. | 48.35M | -3.89% | 176,899 | - |
| 410 | CUE | Cue Biopharma, Inc. | 48.16M | -2.63% | 147,773 | 9.29M |
| 411 | PDSB | PDS Biotechnology Corporation | 47.21M | -6.31% | 151,952 | - |
| 412 | ACET | Adicet Bio, Inc. | 47.16M | -3.58% | 235,015 | - |
| 413 | FBRX | Forte Biosciences, Inc. | 46.04M | 19.78% | 77,181 | - |
| 414 | MAIA | MAIA Biotechnology, Inc. | 45.56M | -1.91% | 22,446 | - |
| 415 | STRO | Sutro Biopharma, Inc. | 45.24M | -6.13% | 1,198,543 | 62.04M |
| 416 | CNTB | Connect Biopharma Holdings Limited | 45.03M | -1.96% | 206,326 | 26.03M |
| 417 | CYCC | Cyclacel Pharmaceuticals, Inc. | 44.87M | -5.67% | 90,763 | 43.00K |
| 418 | IMRX | Immuneering Corporation | 44.86M | -3.88% | 65,303 | - |
| 419 | OTLK | Outlook Therapeutics, Inc. | 44.69M | -1.44% | 267,222 | - |
| 420 | SPRO | Spero Therapeutics, Inc. | 44.69M | 7.39% | 101,770 | 47.98M |
| 421 | FBIO | Fortress Biotech, Inc. | 44.30M | -1.32% | 169,856 | 57.68M |
| 422 | QNCX | Quince Therapeutics, Inc. | 44.00M | -0.99% | 41,395 | - |
| 423 | VRCA | Verrica Pharmaceuticals Inc. | 43.56M | -3.81% | 454,462 | 7.57M |
| 424 | IMMX | Immix Biopharma, Inc. | 43.52M | -6.55% | 29,933 | - |
| 425 | IPSC | Century Therapeutics, Inc. | 43.02M | -0.20% | 520,772 | 6.59M |
| 426 | APLT | Applied Therapeutics, Inc. | 43.01M | -7.43% | 3,383,249 | 455.00K |
| 427 | ANEB | Anebulo Pharmaceuticals, Inc. | 42.73M | 9.47% | - | - |
| 428 | MRSN | Mersana Therapeutics, Inc. | 41.85M | -4.48% | 1,874,245 | 40.50M |
| 429 | PRLD | Prelude Therapeutics Incorporated | 41.83M | 0.82% | 160,968 | 7.00M |
| 430 | AGEN | Agenus Inc. | 41.76M | -2.37% | 262,517 | 103.46M |
| 431 | MURA | Mural Oncology plc | 41.69M | 0.41% | 8,162,783 | - |
| 432 | ADVB | Advanced Biomed Inc. | 41.55M | 1.05% | - | - |
| 433 | ARMP | Armata Pharmaceuticals, Inc. | 41.25M | -0.87% | 3,311 | 5.17M |
| 434 | FBLG | FibroBiologics, Inc. | 41.13M | 13.89% | 480,290 | - |
| 435 | BLUE | bluebird bio, Inc. | 40.63M | -7.16% | 278,781 | 83.81M |
| 436 | PEPG | PepGen Inc. | 40.21M | -6.11% | 128,501 | - |
| 437 | OKUR | OnKure Therapeutics, Inc. | 39.37M | -3.33% | 15,165 | - |
| 438 | XLO | Xilio Therapeutics, Inc. | 39.24M | 6.45% | 255,749 | 6.34M |
| 439 | ATNM | Actinium Pharmaceuticals, Inc. | 38.99M | -2.38% | 188,035 | 81.00K |
| 440 | OKYO | OKYO Pharma Limited | 38.34M | 0.88% | 8,038 | - |
| 441 | ATHE | Alterity Therapeutics Limited | 38.26M | 3.03% | 9,552 | 2.30M |
| 442 | ANTX | AN2 Therapeutics, Inc. | 38.23M | 0.79% | 11,883 | - |
| 443 | LTRN | Lantern Pharma Inc. | 37.64M | -0.85% | 24,924 | - |
| 444 | DYAI | Dyadic International, Inc. | 37.31M | 1.63% | 71,840 | 3.50M |
| 445 | RNXT | RenovoRx, Inc. | 37.28M | 13.33% | 359,279 | 43.00K |
| 446 | KPTI | Karyopharm Therapeutics Inc. | 37.20M | 3.76% | 93,135 | 145.24M |
| 447 | CELU | Celularity Inc. | 36.87M | -5.75% | 11,460 | 48.20M |
| 448 | ITRM | Iterum Therapeutics plc | 36.66M | -5.36% | 326,595 | - |
| 449 | RNTX | Rein Therapeutics Inc. | 36.29M | -4.07% | 16,654 | - |
| 450 | STTK | Shattuck Labs, Inc. | 36.17M | -7.87% | 90,412 | 5.72M |
| 451 | HOWL | Werewolf Therapeutics, Inc. | 36.11M | -6.10% | 174,096 | 1.89M |
| 452 | ATRA | Atara Biotherapeutics, Inc. | 34.22M | -3.51% | 25,809 | 128.94M |
| 453 | XFOR | X4 Pharmaceuticals, Inc. | 33.92M | -5.87% | 1,706,230 | 2.56M |
| 454 | IRD | Opus Genetics, Inc. | 33.77M | -7.42% | 176,022 | 10.99M |
| 455 | OSTX | OS Therapies Incorporated | 33.15M | 6.25% | 279,909 | - |
| 456 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 33.14M | -5.96% | 280,283 | - |
| 457 | NRXP | NRx Pharmaceuticals, Inc. | 32.65M | -1.52% | 38,705 | - |
| 458 | CAMP | Camp4 Therapeutics Corporation | 32.64M | -12.43% | 41,221 | 652.00K |
| 459 | LVTX | LAVA Therapeutics N.V. | 32.36M | 10.53% | 181,118 | 11.98M |
| 460 | RADX | Radiopharm Theranostics Limited | 31.30M | -0.75% | 84,093 | 204.61K |
| 461 | COEP | Coeptis Therapeutics Holdings, Inc. | 31.21M | -0.48% | 24,852 | - |
| 462 | INKT | MiNK Therapeutics, Inc. | 31.06M | 1.03% | 2,805 | - |
| 463 | CVKD | Cadrenal Therapeutics, Inc. | 30.45M | -0.74% | 12,049 | - |
| 464 | ESLA | Estrella Immunopharma, Inc. | 30.25M | -1.72% | 21,958 | - |
| 465 | CASI | CASI Pharmaceuticals, Inc. | 29.90M | -3.02% | 4,494 | 28.54M |
| 466 | ALXO | ALX Oncology Holdings Inc. | 29.90M | 2.71% | 408,378 | - |
| 467 | KZR | Kezar Life Sciences, Inc. | 29.66M | -1.22% | 18,606 | - |
| 468 | BOLD | Boundless Bio, Inc. | 29.21M | -2.96% | 37,910 | - |
| 469 | ALLK | Allakos Inc. | 29.19M | - | 337,241 | - |
| 470 | LSB | LakeShore Biopharma Co., Ltd | 28.62M | -9.09% | 39,846 | 79.42M |
| 471 | BRNS | Barinthus Biotherapeutics plc | 28.44M | 3.52% | 7,296 | 14.97M |
| 472 | INTS | Intensity Therapeutics, Inc. | 28.24M | -2.62% | 4,366 | - |
| 473 | PLUR | Pluri Inc. | 28.13M | -4.24% | - | 678.00K |
| 474 | CLGN | CollPlant Biotechnologies Ltd. | 28.12M | 0.20% | 6,056 | 515.00K |
| 475 | PYPD | PolyPid Ltd. | 28.02M | 1.89% | 9,320 | - |
| 476 | FGEN | FibroGen, Inc. | 28.01M | -6.28% | 456,793 | 29.62M |
| 477 | GRCE | Grace Therapeutics, Inc. | 27.98M | -5.56% | 8,448 | - |
| 478 | MLEC | Moolec Science SA | 27.63M | -0.17% | - | 5.44M |
| 479 | ALGS | Aligos Therapeutics, Inc. | 27.45M | -4.87% | 99,057 | 3.95M |
| 480 | AKTX | Akari Therapeutics, Plc | 27.23M | -8.26% | 10,098 | - |
| 481 | GDTC | CytoMed Therapeutics Limited | 26.89M | -0.43% | 6,570 | 330.25K |
| 482 | VYNE | VYNE Therapeutics Inc. | 26.77M | -0.82% | 115,074 | 501.00K |
| 483 | OSRH | OSR Holdings, Inc. | 26.02M | -6.90% | 103,115 | - |
| 484 | DARE | Daré Bioscience, Inc. | 25.75M | -1.36% | 2,033 | 9.78K |
| 485 | TPST | Tempest Therapeutics, Inc. | 25.37M | - | 34,808 | - |
| 486 | NRSN | NeuroSense Therapeutics Ltd. | 24.71M | -2.83% | 77,945 | - |
| 487 | LEXX | Lexaria Bioscience Corp. | 24.58M | -2.10% | 28,931 | 525.92K |
| 488 | ANVS | Annovis Bio, Inc. | 24.55M | 2.87% | 126,251 | - |
| 489 | ASBP | Aspire Biopharma Holdings, Inc. | 24.44M | -4.52% | 63,187 | - |
| 490 | GBIO | Generation Bio Co. | 23.48M | -4.73% | 386,224 | 19.89M |
| 491 | JUNS | Jupiter Neurosciences, Inc. | 23.39M | 21.84% | 1,253,438 | - |
| 492 | CGTX | Cognition Therapeutics, Inc. | 23.13M | -4.41% | 281,115 | - |
| 493 | QTTB | Q32 Bio Inc. | 22.57M | -8.68% | 97,184 | - |
| 494 | KALA | KALA BIO, Inc. | 22.39M | -3.68% | 8,467 | - |
| 495 | IGC | IGC Pharma, Inc. | 22.31M | -3.65% | 114,912 | 1.24M |
| 496 | NNVC | NanoViricides, Inc. | 21.90M | 4.14% | 325,376 | - |
| 497 | CMMB | Chemomab Therapeutics Ltd. | 21.87M | -4.96% | 17,396 | - |
| 498 | LGVN | Longeveron Inc. | 21.05M | -3.08% | 60,004 | 2.39M |
| 499 | CALC | CalciMedica, Inc. | 20.76M | -3.13% | 14,402 | - |
| 500 | PASG | Passage Bio, Inc. | 20.45M | -8.92% | 270,802 | - |
| 501 | ENLV | Enlivex Therapeutics Ltd. | 20.34M | -3.53% | 40,918 | - |
| 502 | PULM | Pulmatrix, Inc. | 20.14M | 2.13% | 4,039 | 7.81M |
| 503 | PMN | ProMIS Neurosciences, Inc. | 20.07M | 9.64% | 17,233 | - |
| 504 | CVM | CEL-SCI Corporation | 19.87M | 6.63% | 1,107,048 | - |
| 505 | KZIA | Kazia Therapeutics Limited | 19.78M | -2.37% | 72,834 | 1.66M |
| 506 | ELEV | Elevation Oncology, Inc. | 19.58M | 5.49% | 3,461,300 | - |
| 507 | IPA | ImmunoPrecise Antibodies Ltd. | 19.54M | -0.46% | 100,231 | 16.58M |
| 508 | CDIO | Cardio Diagnostics Holdings, Inc. | 19.51M | -6.19% | 601,090 | 34.89K |
| 509 | OVID | Ovid Therapeutics Inc. | 19.20M | -5.69% | 236,526 | 566.00K |
| 510 | BCAB | BioAtla, Inc. | 18.69M | 0.60% | 128,341 | 11.00M |
| 511 | CANF | Can-Fite BioPharma Ltd. | 17.95M | -2.38% | 261,595 | 674.00K |
| 512 | LSTA | Lisata Therapeutics, Inc. | 17.66M | -3.23% | 4,711 | 1.00M |
| 513 | CLDI | Calidi Biotherapeutics, Inc. | 16.67M | -5.42% | 182,550 | - |
| 514 | BCTX | BriaCell Therapeutics Corp. | 16.49M | 19.47% | 19,851,986 | - |
| 515 | LPCN | Lipocine Inc. | 16.10M | -1.31% | - | 11.20M |
| 516 | UBX | Unity Biotechnology, Inc. | 16.06M | -1.86% | 68,197 | - |
| 517 | EDSA | Edesa Biotech, Inc. | 15.87M | -0.04% | 17,553 | - |
| 518 | EQ | Equillium, Inc. | 15.58M | -5.53% | 72,231 | 41.10M |
| 519 | CING | Cingulate Inc. | 15.53M | -4.85% | 77,937 | - |
| 520 | LPTX | Leap Therapeutics, Inc. | 15.22M | -1.42% | 194,140 | - |
| 521 | BIVI | BioVie Inc. | 14.64M | -3.40% | 70,410 | - |
| 522 | GLYC | GlycoMimetics, Inc. | 14.32M | -2.55% | 82,170 | - |
| 523 | ALLR | Allarity Therapeutics, Inc. | 13.56M | -5.28% | 696,154 | - |
| 524 | PHGE | BiomX Inc. | 13.49M | -5.56% | 46,006 | - |
| 525 | SLGL | Sol-Gel Technologies Ltd. | 13.37M | -4.00% | - | 11.71M |
| 526 | COCP | Cocrystal Pharma, Inc. | 13.33M | -2.24% | 2,820 | - |
| 527 | CLRB | Cellectar Biosciences, Inc. | 13.08M | -3.34% | 562,498 | - |
| 528 | MEIP | MEI Pharma, Inc. | 12.99M | -4.41% | 12,357 | - |
| 529 | BRTX | BioRestorative Therapies, Inc. | 12.98M | -3.37% | 31,253 | 401.00K |
| 530 | SABS | SAB Biotherapeutics, Inc. | 12.91M | 0.72% | 28,258 | 1.32M |
| 531 | PHIO | Phio Pharmaceuticals Corp. | 12.90M | 11.11% | 2,520,662 | - |
| 532 | MBRX | Moleculin Biotech, Inc. | 12.87M | 8.24% | 871,640 | - |
| 533 | INAB | IN8bio, Inc. | 12.81M | -3.43% | 632,026 | - |
| 534 | BOLT | Bolt Biotherapeutics, Inc. | 12.73M | -3.77% | 62,635 | 7.69M |
| 535 | ABP | Abpro Holdings, Inc. | 12.60M | -6.46% | 184,415 | 183.00K |
| 536 | GOVX | GeoVax Labs, Inc. | 12.49M | 6.09% | 665,012 | 3.95M |
| 537 | IMNN | Imunon, Inc. | 12.49M | -1.92% | 30,040 | - |
| 538 | KAPA | Kairos Pharma, Ltd. | 12.43M | -7.82% | 112,066 | - |
| 539 | ABVC | ABVC BioPharma, Inc. | 12.06M | 10.02% | 278,072 | 509.59K |
| 540 | NRXS | NeurAxis, Inc. | 11.98M | -2.35% | 50,425 | 2.69M |
| 541 | AFMD | Affimed N.V. | 11.90M | 0.69% | 47,957 | 6.29M |
| 542 | SYBX | Synlogic, Inc. | 11.81M | - | - | 8.00K |
| 543 | MRKR | Marker Therapeutics, Inc. | 11.57M | -9.40% | 20,460 | 6.59M |
| 544 | PSTV | Plus Therapeutics, Inc. | 11.42M | 3.18% | 1,287,448 | 5.82M |
| 545 | ICU | SeaStar Medical Holding Corporation | 11.16M | -3.85% | 60,113 | 135.00K |
| 546 | PRTG | Portage Biotech Inc. | 11.11M | -15.52% | 71,665 | - |
| 547 | CRIS | Curis, Inc. | 10.95M | - | 49,068 | 10.91M |
| 548 | XTLB | XTL Biopharmaceuticals Ltd. | 10.76M | 2.73% | 3,483 | 46.00K |
| 549 | SNSE | Sensei Biotherapeutics, Inc. | 10.57M | -10.33% | 111,855 | - |
| 550 | RLYB | Rallybio Corporation | 10.48M | -2.21% | 213,521 | 636.00K |
| 551 | NERV | Minerva Neurosciences, Inc. | 10.32M | - | - | - |
| 552 | HOTH | Hoth Therapeutics, Inc. | 10.19M | -4.04% | 221,862 | - |
| 553 | TRAW | Traws Pharma, Inc. | 10.10M | -6.57% | 17,028 | 226.00K |
| 554 | BTAI | BioXcel Therapeutics, Inc. | 9.95M | - | 33,075 | 2.27M |
| 555 | HOOK | HOOKIPA Pharma Inc. | 9.70M | -2.48% | 17,054 | 43.95M |
| 556 | RLMD | Relmada Therapeutics, Inc. | 9.69M | -5.19% | 138,002 | - |
| 557 | BLRX | BioLineRx Ltd. | 9.69M | 0.89% | 57,826 | 28.94M |
| 558 | IBIO | iBio, Inc. | 9.68M | -10.92% | 650,845 | 375.00K |
| 559 | ERNA | Ernexa Therapeutics Inc. | 9.60M | -8.24% | 81,435 | 582.00K |
| 560 | IMRN | Immuron Limited | 9.59M | -1.16% | 4,390 | 4.05M |
| 561 | NXTC | NextCure, Inc. | 9.38M | 1.20% | 488,303 | - |
| 562 | NEUP | Neuphoria Therapeutics Inc. | 8.98M | -1.16% | 7,691 | 662.72K |
| 563 | ATHA | Athira Pharma, Inc. | 8.94M | -3.00% | 91,523 | - |
| 564 | BCDA | BioCardia, Inc. | 8.94M | -6.83% | 14,695 | 58.00K |
| 565 | CSCI | COSCIENS Biopharma Inc. | 8.70M | -0.70% | 3,547 | 9.59M |
| 566 | HCWB | HCW Biologics Inc. | 8.57M | -8.73% | - | 2.57M |
| 567 | CTXR | Citius Pharmaceuticals, Inc. | 8.50M | -5.00% | 60,399 | - |
| 568 | ACXP | Acurx Pharmaceuticals, Inc. | 8.49M | 2.63% | 67,868 | - |
| 569 | APRE | Aprea Therapeutics, Inc. | 8.44M | -1.90% | 8,593 | 1.50M |
| 570 | CARM | Carisma Therapeutics, Inc. | 8.40M | 5.08% | 50,444 | 19.63M |
| 571 | RNAZ | TransCode Therapeutics, Inc. | 8.32M | -10.40% | 2,433,885 | - |
| 572 | KPRX | Kiora Pharmaceuticals, Inc. | 8.25M | -1.29% | 12,759 | 16.02M |
| 573 | EVAX | Evaxion Biotech A/S | 8.21M | -2.96% | 34,240 | 3.34M |
| 574 | PMCB | PharmaCyte Biotech, Inc. | 8.13M | -7.09% | 23,333 | - |
| 575 | TSBX | Turnstone Biologics Corp. | 7.94M | -8.31% | 94,444 | - |
| 576 | CHRO | Channel Therapeutics Corporation | 7.66M | - | - | - |
| 577 | OCEA | Ocean Biomedical, Inc. | 7.17M | -1.82% | 6,843,283 | - |
| 578 | INDP | Indaptus Therapeutics, Inc. | 6.97M | -4.22% | 18,590 | - |
| 579 | PPBT | Purple Biotech Ltd | 6.90M | 2.00% | 7,888 | - |
| 580 | CYCN | Cyclerion Therapeutics, Inc. | 6.82M | -0.37% | 3,398 | 2.00M |
| 581 | EVGN | Evogene Ltd. | 6.57M | 0.04% | 6,745 | 8.51M |
| 582 | APM | Aptorum Group Limited | 6.54M | -15.28% | 225,200 | - |
| 583 | SNGX | Soligenix, Inc. | 6.50M | 3.00% | 112,038 | 119.37K |
| 584 | APLM | Apollomics, Inc. | 6.50M | 6.13% | 176,415 | 198.00K |
| 585 | SLXN | Silexion Therapeutics Corp | 6.49M | -2.47% | 139,082 | - |
| 586 | PTN | Palatin Technologies, Inc. | 6.40M | 19.82% | 4,447,788 | 350.00K |
| 587 | MTVA | MetaVia Inc. | 6.36M | -9.35% | 1,293,720 | - |
| 588 | GNPX | Genprex, Inc. | 6.17M | -1.73% | 1,400,870 | - |
| 589 | LIPO | Lipella Pharmaceuticals Inc. | 6.14M | -1.65% | 2,836 | 536.36K |
| 590 | LYRA | Lyra Therapeutics, Inc. | 6.06M | -0.22% | 1,051,815 | 1.53M |
| 591 | ADXN | Addex Therapeutics Ltd | 6.02M | 3.77% | 1,352 | 701.26K |
| 592 | IBO | Impact BioMedical Inc. | 5.28M | -14.31% | 820,885 | - |
| 593 | CDT | Conduit Pharmaceuticals Inc. | 5.20M | -12.97% | 3,845,480 | - |
| 594 | SPRB | Spruce Biosciences, Inc. | 5.19M | -6.82% | 4,427,789 | 4.91M |
| 595 | BCLI | Brainstorm Cell Therapeutics Inc. | 5.19M | 2.19% | 108,334 | - |
| 596 | GTBP | GT Biopharma, Inc. | 5.03M | -5.06% | 11,983 | - |
| 597 | DWTX | Dogwood Therapeutics, Inc. | 4.97M | -10.34% | 720,481 | - |
| 598 | NCNA | NuCana plc | 4.93M | - | 59,518 | - |
| 599 | CMND | Clearmind Medicine Inc. | 4.80M | 1.63% | 216,355 | - |
| 600 | KLTO | Klotho Neurosciences, Inc. | 4.77M | -5.06% | 59,470 | - |
| 601 | AZTR | Azitra, Inc. | 4.76M | 7.88% | 523,240 | 7.50K |
| 602 | ALZN | Alzamend Neuro, Inc. | 4.74M | -5.43% | 143,624 | - |
| 603 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.67M | -8.12% | 92,019 | 681.35K |
| 604 | SILO | Silo Pharma, Inc. | 4.62M | -0.96% | 47,376 | 72.10K |
| 605 | ADIL | Adial Pharmaceuticals, Inc. | 4.61M | -4.00% | 6,317 | - |
| 606 | ATNF | 180 Life Sciences Corp. | 4.55M | -10.02% | 73,696 | - |
| 607 | VRAX | Virax Biolabs Group Limited | 4.47M | -2.83% | 36,010 | 84.87K |
| 608 | MBIO | Mustang Bio, Inc. | 4.43M | -1.47% | - | - |
| 609 | TCRT | Alaunos Therapeutics, Inc. | 4.28M | -5.86% | 27,712 | 10.00K |
| 610 | AEON | AEON Biopharma, Inc. | 4.21M | -1.74% | 120,088 | - |
| 611 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 3.86M | -1.56% | 12,724 | 1.00M |
| 612 | OGEN | Oragenics, Inc. | 3.84M | -4.13% | 142,330 | - |
| 613 | DRMA | Dermata Therapeutics, Inc. | 3.80M | -10.13% | 115,466 | - |
| 614 | HEPA | Hepion Pharmaceuticals, Inc. | 3.76M | -2.00% | 1,047,857 | - |
| 615 | JAGX | Jaguar Health, Inc. | 3.72M | 7.93% | 172,778 | 11.69M |
| 616 | XBIO | Xenetic Biosciences, Inc. | 3.72M | -2.82% | 5,829 | 2.50M |
| 617 | KTTA | Pasithea Therapeutics Corp. | 3.71M | 3.79% | 292,133 | - |
| 618 | TOVX | Theriva Biologics, Inc. | 3.67M | -1.72% | 8,060 | - |
| 619 | XRTX | XORTX Therapeutics Inc. | 3.66M | 2.22% | - | - |
| 620 | QNRX | Quoin Pharmaceuticals, Ltd. | 3.53M | - | 79,900 | - |
| 621 | CELZ | Creative Medical Technology Holdings, Inc. | 3.46M | -4.88% | 40,462 | 11.00K |
| 622 | TTNP | Titan Pharmaceuticals, Inc. | 3.44M | 1.08% | - | - |
| 623 | NBY | NovaBay Pharmaceuticals, Inc. | 3.42M | -0.34% | 46,004 | 9.78M |
| 624 | LIXT | Lixte Biotechnology Holdings, Inc. | 3.29M | 0.81% | 3,798 | - |
| 625 | ARTL | Artelo Biosciences, Inc. | 3.18M | -5.83% | 231,393 | - |
| 626 | GLTO | Galecto, Inc. | 3.15M | -6.61% | 11,745 | - |
| 627 | SNPX | Synaptogenix, Inc. | 3.11M | 2.52% | 1,797 | - |
| 628 | PALI | Palisade Bio, Inc. | 3.08M | 3.77% | 33,497 | - |
| 629 | GLMD | Galmed Pharmaceuticals Ltd. | 3.07M | -7.09% | 51,098 | - |
| 630 | ENVB | Enveric Biosciences, Inc. | 2.99M | -2.65% | 23,513 | - |
| 631 | APVO | Aptevo Therapeutics Inc. | 2.88M | -6.94% | 261,371 | - |
| 632 | MTNB | Matinas BioPharma Holdings, Inc. | 2.87M | 0.86% | 26,265 | - |
| 633 | REVB | Revelation Biosciences, Inc. | 2.72M | -1.64% | 116,326 | - |
| 634 | ENSC | Ensysce Biosciences, Inc. | 2.64M | -16.07% | 367,789 | 5.21M |
| 635 | ADTX | Aditxt, Inc. | 2.55M | -8.71% | 295,547 | 133.99K |
| 636 | TNFA | TNF Pharmaceuticals, Inc. | 2.49M | -9.00% | 3,991,094 | - |
| 637 | QLGN | Qualigen Therapeutics, Inc. | 2.42M | 2.12% | 75,420 | - |
| 638 | CNSP | CNS Pharmaceuticals, Inc. | 2.41M | -14.31% | 335,226 | - |
| 639 | ONVO | Organovo Holdings, Inc. | 2.41M | - | 128,309 | 122.00K |
| 640 | THAR | Tharimmune, Inc. | 2.38M | -1.74% | 4,295 | - |
| 641 | NLSP | NLS Pharmaceutics AG | 2.30M | -5.33% | 76,333 | - |
| 642 | EYEN | Eyenovia, Inc. | 2.30M | -1.79% | - | 57.34K |
| 643 | PBM | Psyence Biomedical Ltd. | 2.06M | -5.91% | 46,676 | - |
| 644 | PTIX | Protagenic Therapeutics, Inc. | 1.93M | -10.73% | 132,432 | - |
| 645 | ZVSA | ZyVersa Therapeutics, Inc. | 1.83M | -7.67% | 417,521 | - |
| 646 | ELAB | PMGC Holdings Inc. | 1.82M | -11.34% | 1,327,406 | 2.45M |
| 647 | ENTO | Entero Therapeutics, Inc. | 1.82M | -4.77% | 39,357 | - |
| 648 | SCNI | Scinai Immunotherapeutics Ltd. | 1.64M | - | 19,367 | 452.00K |
| 649 | PLRZ | Polyrizon Ltd. | 1.52M | -3.97% | 35,063 | - |
| 650 | VINC | Vincerx Pharma, Inc. | 1.44M | 7.34% | 1,550,327 | - |
| 651 | PCSA | Processa Pharmaceuticals, Inc. | 1.34M | -5.96% | 1,564,348 | - |
| 652 | SLRX | Salarius Pharmaceuticals, Inc. | 1.17M | -6.72% | 54,287 | - |
| 653 | CERO | CERo Therapeutics Holdings, Inc. | 1.15M | 2.05% | 239,426 | - |
| 654 | NAYA | INVO Fertility, Inc. | 1.09M | -2.65% | 15,722 | - |
| 655 | BDRX | Biodexa Pharmaceuticals Plc | 976.14K | - | 99,326 | 104.90K |
| 656 | SPRC | SciSparc Ltd. | 970.40K | -6.04% | 66,797 | 1.75M |
| 657 | WINT | Windtree Therapeutics, Inc. | 846.76K | -3.39% | 222,621 | - |
| 658 | GRI | GRI Bio, Inc. | 803.80K | -2.55% | 164,189 | - |
| 659 | SCPX | Scorpius Holdings, Inc. | 621.68K | -7.46% | 281,821 | 10.04M |
| 660 | ONCO | Onconetix, Inc. | 494.37K | -8.02% | 1,555,802 | 1.87M |